Merck & Co., Inc. Quarterly Inventory, Net in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Merck & Co., Inc. quarterly Inventory, Net history and growth rate from Q1 2010 to Q2 2024.
  • Merck & Co., Inc. Inventory, Net for the quarter ending June 30, 2024 was $6.47B, a 9.09% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.47B +$539M +9.09% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $6.51B +$647M +11% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $6.36B +$447M +7.56% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $6.13B +$517M +9.21% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $5.93B +$395M +7.14% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.86B +$89M +1.54% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $5.91B -$42M -0.71% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $5.61B +$11M +0.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.54B +$36M +0.66% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $5.77B -$628M -9.81% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $5.95B +$399M +7.18% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $5.6B -$525M -8.57% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $5.5B -$557M -9.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $6.4B +$556M +9.51% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $5.55B -$424M -7.09% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $6.13B +$273M +4.66% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $6.06B +$209M +3.57% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $5.85B +$134M +2.35% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $5.98B +$538M +9.89% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $5.86B +$439M +8.11% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $5.85B +$669M +12.9% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $5.71B +$330M +6.13% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $5.44B +$344M +6.75% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $5.42B +$153M +2.91% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $5.18B -$229M -4.24% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $5.38B +$236M +4.59% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $5.1B +$230M +4.73% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $5.26B +$19M +0.36% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $5.41B +$159M +3.03% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $5.15B +$44M +0.86% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $4.87B +$166M +3.53% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $5.24B +$121M +2.36% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $5.25B -$58M -1.09% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $5.1B -$437M -7.89% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $4.7B -$871M -15.6% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $5.12B -$696M -12% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $5.31B -$830M -13.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $5.54B -$837M -13.1% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $5.57B -$655M -10.5% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $5.82B -$922M -13.7% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $6.14B -$630M -9.31% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $6.38B -$397M -5.86% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $6.23B -$309M -4.73% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $6.74B +$10M +0.15% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $6.77B +$517M +8.27% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $6.77B +$434M +6.85% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $6.54B +$281M +4.49% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $6.73B +$492M +7.89% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $6.25B +$24M +0.39% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $6.34B +$282M +4.66% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $6.25B +$386M +6.58% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $6.24B -$24.6M -0.39% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $6.23B -$19.2M -0.31% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $6.06B -$768M -11.3% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $5.87B Dec 31, 2010 10-K 2012-02-28
Q3 2010 $6.26B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $6.24B Jun 30, 2010 10-Q 2010-08-06
Q1 2010 $6.83B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.